LifeAire Systems, LLC

Engage a consultant to complete development of a new marketing strategy for this producer of proprietary in-duct air purification systems for highly sensitive environments. Originally developed for In Vitro Fertilization laboratories, the LifeAire Systems’ technology is also being used to address hospital acquired infections (HAI) in the healthcare setting and in the support of the living cell environment in life sciences and biopharma. Research indicates that 1.7 million patients in the U.S. acquire an HAI each year with an associated cost burden of $35-88B annually. These infections create avoidable complications, and contribute to increased readmission rates, morbidity, mortality, and significant additional costs borne by the hospital.